A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss - Concepedia

Concepedia

Publication | Open Access

A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

DOI Full Paper Access

171

Citations

14

References

2018

Year

Frank L. Greenway, Louis J. Aronne, Anne Raben, Arne Astrup, Caroline M. Apovian, James O. Hill, Lee M. Kaplan, Ken Fujioka, Erika Matejkova, Š Svačina,

Abstract

Gelesis100 is a promising new nonsystemic therapy for overweight and obesity with a highly desirable safety and tolerability profile.

References

	Year	Citations

Page 1